NO942553L - Ny humanproteaseinhibitor av Kunitz-type og varianter derav - Google Patents

Ny humanproteaseinhibitor av Kunitz-type og varianter derav

Info

Publication number
NO942553L
NO942553L NO942553A NO942553A NO942553L NO 942553 L NO942553 L NO 942553L NO 942553 A NO942553 A NO 942553A NO 942553 A NO942553 A NO 942553A NO 942553 L NO942553 L NO 942553L
Authority
NO
Norway
Prior art keywords
phe
cys
gly
glu
protease inhibitor
Prior art date
Application number
NO942553A
Other languages
English (en)
Norwegian (no)
Other versions
NO942553D0 (no
Inventor
Fanny Norris
Kjeld Norris
Soeren Erik Bjoern
Lars Christian Petersen
Ole Hvilsted Olsen
Donald Cameron Foster
Cindy Ann Sprecher
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO942553D0 publication Critical patent/NO942553D0/no
Publication of NO942553L publication Critical patent/NO942553L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
NO942553A 1992-01-07 1994-07-06 Ny humanproteaseinhibitor av Kunitz-type og varianter derav NO942553L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK9200003 1992-01-07
PCT/DK1993/000006 WO1993014123A1 (en) 1992-01-07 1993-01-07 A novel human kunitz-type protease inhibitor and variants thereof

Publications (2)

Publication Number Publication Date
NO942553D0 NO942553D0 (no) 1994-07-06
NO942553L true NO942553L (no) 1994-09-07

Family

ID=8153772

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942553A NO942553L (no) 1992-01-07 1994-07-06 Ny humanproteaseinhibitor av Kunitz-type og varianter derav

Country Status (17)

Country Link
US (1) US5618696A (de)
EP (1) EP0621873B1 (de)
JP (1) JP3345420B2 (de)
KR (1) KR940703860A (de)
AT (1) ATE171712T1 (de)
AU (1) AU670059B2 (de)
CA (1) CA2127247A1 (de)
CZ (1) CZ164894A3 (de)
DE (1) DE69321342T2 (de)
ES (1) ES2123635T3 (de)
FI (1) FI943235A (de)
HU (1) HUT70291A (de)
IL (1) IL104314A0 (de)
NO (1) NO942553L (de)
NZ (1) NZ246571A (de)
WO (1) WO1993014123A1 (de)
ZA (1) ZA9394B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060134087A1 (en) * 1988-09-02 2006-06-22 Dyax Corp. ITI-D1 Kunitz domain mutants as hNE inhibitors
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US5795954A (en) * 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins
US5786328A (en) * 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
US5780265A (en) * 1995-06-05 1998-07-14 Genentech, Inc. Kunitz type plasma kallikrein inhibitors
US6242414B1 (en) 1995-06-07 2001-06-05 Chiron Corporation Regulation of cytokine synthesis and release
ATE477020T1 (de) 2002-06-07 2010-08-15 Dyax Corp Prevention und verringerung von ischemia
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
DE602004031589D1 (de) * 2003-01-07 2011-04-14 Dyax Corp Kunitz-domäne-bibliothek
MX2007000473A (es) * 2004-07-13 2007-03-29 Bayer Pharmaceuticals Corp Variantes mejoradas de la aprotinina.
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
SI1981519T1 (en) 2005-12-29 2018-05-31 Dyax Corp. INHIBITION PROTEAZE
WO2009026334A2 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
WO2009080054A1 (en) * 2007-12-21 2009-07-02 Ifxa A/S Protease inhibitor
DK2379096T3 (da) 2008-12-19 2019-11-25 Baxalta GmbH TFPI-inhibitorer og fremgangsmåder til anvendelse
US8450275B2 (en) 2010-03-19 2013-05-28 Baxter International Inc. TFPI inhibitors and methods of use
AU2010203712A1 (en) * 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
JP6037841B2 (ja) * 2010-01-06 2016-12-07 ダイアックス コーポレーション 血漿カリクレイン結合タンパク質
AU2012204202A1 (en) 2011-01-06 2013-07-11 Dyax Corp. Plasma kallikrein binding proteins
HUE046572T2 (hu) 2012-03-21 2020-03-30 Baxalta GmbH TFPI inhibitorok és alkalmazási eljárások
US10428158B2 (en) 2014-03-27 2019-10-01 Dyax Corp. Compositions and methods for treatment of diabetic macular edema
CN108602893A (zh) 2015-12-11 2018-09-28 戴埃克斯有限公司 血浆激肽释放酶抑制剂及其治疗遗传性血管性水肿发作的用途
AU2017277647B2 (en) * 2016-06-08 2023-07-27 President And Fellows Of Harvard College Engineered viral vector reduces induction of inflammatory and immune responses
JP2021502381A (ja) 2017-11-08 2021-01-28 プレジデント アンド フェローズ オブ ハーバード カレッジ ウイルスベクター誘発性炎症反応を阻害するための組成物および方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2199582A (en) * 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor
DE3724570A1 (de) * 1987-06-27 1989-01-05 Bayer Ag Human-aprotinin, dessen lys-rest in position 15 gegen einen anderen protogenen aminosaeurerest ausgetauscht ist
US5106833A (en) * 1987-07-23 1992-04-21 Washington University Coagulation inhibitors
US4966852A (en) * 1987-07-23 1990-10-30 Monsanto Company DNA clone of human tissue factor inhibitor
DK225488D0 (da) * 1988-04-26 1988-04-26 Novo Industri As Polypeptid
JPH07102137B2 (ja) * 1988-07-19 1995-11-08 塩野義製薬株式会社 修飾ヒトｐｓｔｉ

Also Published As

Publication number Publication date
AU670059B2 (en) 1996-07-04
JP3345420B2 (ja) 2002-11-18
EP0621873A1 (de) 1994-11-02
EP0621873B1 (de) 1998-09-30
HUT70291A (en) 1995-09-28
ATE171712T1 (de) 1998-10-15
AU3346193A (en) 1993-08-03
US5618696A (en) 1997-04-08
WO1993014123A1 (en) 1993-07-22
DE69321342T2 (de) 1999-04-01
FI943235A0 (fi) 1994-07-06
DE69321342D1 (de) 1998-11-05
ES2123635T3 (es) 1999-01-16
ZA9394B (en) 1993-08-10
NO942553D0 (no) 1994-07-06
HU9401989D0 (en) 1994-09-28
KR940703860A (ko) 1994-12-12
CZ164894A3 (en) 1994-12-15
NZ246571A (en) 1996-09-25
CA2127247A1 (en) 1993-07-22
FI943235A (fi) 1994-07-06
JPH07504652A (ja) 1995-05-25
IL104314A0 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
NO942553D0 (no) Ny humanproteaseinhibitor av Kunitz-type og varianter derav
HK1154211A1 (zh) 預防和減少失血和炎症反應
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
DE69128664D1 (de) CNP-Gen und Vorläuferprotein aus Schwein
YU29596A (sh) Genski proizvodi koji regulišu gojaznost
NZ334714A (en) Liver proteins as agents against autoimmune diseases
ATE124955T1 (de) Substrat-peptide.
ES2171157T3 (es) Gen recombinante codificante para una proteina con actividad endoquitinasa.
RU94036002A (ru) Ингибитор протеазы, днк, вектор, клетка, способ получения ингибитора, фармацевтическая композиция
EP1225184A4 (de) Menschliche antithrombin-varianten
WO1999057262A3 (de) An metallionen bindendes peptid
ATE305478T1 (de) Topoisomerase-ii inhibitoren
PT100299A (pt) Analogo de hirudina, metodo para a sua producao e anti-coagulante contendo-o, e vector de secrecao , microorganismos transformados com o referido vector e metodo para a producao de produtos a partir dos referidos microorganismos
ECSP972344A (es) Proteinas antiobesidad